Banknote printer De La Rue has said it believes takeover talks will reach a “successful conclusion in the coming months”, as it reported a dent in full year revenue. The …
Retirement Planning
Andy Murray withdraws from Roland Garros singles at Olympic Games
Andy Murray’s farewell tour to tennis took a hit this morning with the Brit withdrawing from the Olympic Games singles. The two-time gold medal winner took the decision on the …
Yorkshire Building Society sees profit fall as rate tailwind eases
Profit fell at Yorkshire Building Society as margins in the mortgage market were compressed by the plateau in interest rates. In the first six months of the year, the building …
British American Tobacco: Lucky Strike maker holds guidance but vapes and tobacco sales disappoint
British American Tobacco (BAT) has maintained its full year guidance, but revenue and profit both declined. The tobacco and e-cigarette manufacturer reported that revenue fell by 8.2 per cent year …
Veterinary group CVS gears up for Australia expansion
Veterinary group CVS announced 10 per cent revenue growth but weaker sales amid soft demand and the effect of a cyber security attack, while it separately announced a shift in …
‘So much of the world is controllable – sport isn’t like that. That’s the beauty of it’
A triathlon in London “just feels right”, says Alistair Brownlee, and he should know. The sport’s only double Olympic champion won gold on home soil in 2012 and it remains …
GB Energy to work with Crown Estate to develop offshore wind farms, says government
Britain’s newly created state-owned energy company, Great British Energy, is to partner with the monarchy’s property firm to help speed up the building of offshore wind farms. The Crown Estate …
Tate & Lyle: Revenue dips after it passes cost savings on to customers
Speciality ingredient specialist Tate & Lyle has reported a dip in revenue despite high volumes as it has passed cost savings onto customers. In a trading update issued today ahead …
Astrazeneca: FTSE giant lifts forecast as new drugs drive revenue growth
FTSE 100 heavyweight Astrazeneca has upgraded its full-year revenue and earnings per share (EPS) forecasts, fuelled by a surge in revenues from new medicines. Total revenue and core EPS are …
Rentokil: Stock falls as company fails to impress while takeover rumours swirl
Rentokil shares fell over five per cent this morning after the company issued what could be described as a bland set of results. While the company, which has been the …